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TO THE EDITOR
There is a lack of definitive epidemiolo-
gic information on patients who suffer
from hidradenitis suppurativa (HS), as
well as poor understanding of the etiol-
ogy of this process. It is essential to
gather more accurate information regard-
ing HS as understanding of disease
associations may lead to improved com-
prehension of the pathology. In their
recent report, Vazques et al. (2013)
have put forth an excellent population-
based study on this disease process,
which helps to provide valuable infor-
mation on such associations. They
found that 90.3% of the patients with
HS in Olmsted County, Minnesota, were
white, but specifically note that this
racial breakdown may be a reflection
of the racial demographics of the county
itself, which is predominantly white.
The classical teaching regarding HS
has been that this process occurs more
frequently in those of African descent
(McMichael et al., 2008). However,
many of the published epidemiologic
studies are similar to this publication in
reporting a predominance of whites
among those affected. It is important to
consider that many of these studies are
drawn from the northern or western
European populations. This may again
be a reflection of the demographics of
these regions, but this message domi-
nates the available literature.
Over the last several years, we have
increasingly recognized that there is a
large population of patients in our area
who suffer from follicular disorders,
particularly HS. As such, we have per-
formed our own retrospective review of
all HS patients seen in our clinic during
an 18-month time period from 1 January
2011 to 31 May 2012.
All encounters were searched, and
there were 366 patients identified with
the clinical diagnosis of HS seen in the
Dermatology Clinic at the Henry Ford
Medical Center during this time period.
Given that overall there were 8,480
patients seen in the clinic during this
time, HS patients comprised 4.3% of the
dermatology clinic patient population.
For 6,664 of these patients, including all
366 of the patients with the diagnosis of
HS, there were data available regarding
race. In addition, the US Census Bureau
data for Wayne County, Michigan, in
2010 (http://quickfacts.census.gov/qfd/
states/26/26163lk.html, accessed 21
May 2013) indicate that the population
of Wayne County was 54.2% white and
41.8% black. For the HS patients, 54.4%
(199) were black, 25.7% (94) were
white, and the remaining 19.9% (73)
were classified as ‘‘other.’’ Looking at
the overall population of patients seen in
the Henry Ford Dermatology Clinic for
all diagnoses, 47.0% (3,131) were black,
35.8% (2,389) were white, and 17.2%
(1,144) fell into the category of ‘‘other.’’
We found that 6.4% of the black patients
as compared with 3.9% of the white
patients seen in the clinic were seen for
the diagnosis of HS (P-value ofo0.001),
using a chi-square test, SAS9.2 (SAS,
Cary, NC) (Table 1). We feel our data
support the traditional teaching that HS
is more common in those of African
descent, which is not currently substan-
tiated in the medical literature.
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TO THE EDITOR
Psoriasis is generally considered to be
an immunologically initiated disorder,
which shares certain common suscept-
ibility loci with autoimmune diseases
(Zhang, 2012). Yet, both clinical
experience (Gottlieb et al.,1990;
Griffiths et al., 1995; Volden et al.,
2001) and recent molecular studies
(Mischke et al., 1996; Kim et al., 2011;
Vermeij et al., 2011; Bergboer et al.,
2012) support an emerging concept
that psoriasis could be ‘‘driven’’ by
a primary defect in epidermal permea-
bility barrier function. Clinicians know
well that psoriasis predictably flares
during winter months (Park and Youn,
1998; Kwon et al., 2012) when the
barrier is under additional stress owing
to low stratum corneum (SC) hydration,
which accelerates transepidermal water
loss (TEWL) rates (Lin, 2009;
Muizzuddin et al., 2013). They also
appreciate that sites vulnerable to
epidermal trauma, such as the exten-
sors of the extremities and the scalp,
are preferentially involved in psoriasis.
The Koebner phenomenon offers an
additional, eloquent example of
how psoriasis can be provoked by
external perturbations. Finally, improve-
ment of epidermal permeability barrier
function by occlusion alone often
alleviates psoriasis (e.g., Friedman,
1987).
Among psoriasis susceptibility genes,
PSORS4 is located on chromosome
1q21, within the epidermal differentia-
tion complex, which encodes numerous
proteins required for epidermal differen-
tiation and formation of the cornified
envelope (Mischke et al., 1996), a
structure that is critical for the
permeability barrier (Vermeij et al.,
2011). In addition, deletion of differen-
tiation-related proteins, such as keratin1,
whose levels are reduced in psoriasis
(Thewes et al., 1991; Bata-Cso¨rgo¨ and
Szell, 2012), not only compromises the
permeability barrier but also leads to
upregulation of inflammatory genes and
altered cytokine production in a pattern
that resembles psoriasis (Roth et al.,
2012). Finally, in experimental models,
disruption of the epidermal permeability
barrier in otherwise normal skin
stimulates epidermal hyperproliferation
(Proksch et al., 1991; Man et al., 2008),
cytokine production (Denda et al.,
1996; Wood et al., 1996), downstream
inflammatory cell infiltration (Proksch
et al., 1996; Lin et al., 2013), and
epidermal vascular endothelial growth
factor production, leading to dermal
capillary proliferation (Elias et al.,
2008), all of which are prominent
features of psoriasis.
Although prior studies have demon-
strated phenotype-dependent abnor-
malities in basal permeability barrier
function in psoriatic lesions (Ghadially
et al., 1996), the uninvolved skin in
psoriasis reportedly displays normal
TEWL levels (Takahashi et al., 2014).
Yet, expression levels of filaggrin, a
protein of known importance for the
barrier (Scharschmidt et al., 2009;
Irvine et al., 2011), and loricrin are
reportedly lower than normal in
uninvolved skin sites of psoriasis (Kim
et al., 2011). Because alterations in
the epidermal differentiation should
predict an abnormality in barrier
function, we hypothesized that if
abnormal epidermal function has a
role in the pathogenesis of psoriasis
then epidermal function should
be abnormal in uninvolved psoriatic
skin. Hence, we assessed changes in
epidermal function in the uninvolved
and involved skin of a large cohort of
Chinese patients, with either stable or
progressive psoriasis.
In all, 44 patients with psoriasis
vulgaris and 68 normal controls were
enrolled in the study (Table 1). All parti-
cipants were provided written informed
consent. This study was carried out
according to the Helsinki Declaration
Principles and the protocol approved by
the Human Research Subcommittee,
Dalian Skin Disease Hospital. Stable
psoriasis was defined as no recent
development of new lesions, as well as
no recent expansion of pre-existing
lesions, whereas progressive psoriasis
was defined as recent or ongoing devel-
opment of new lesions and prominent
inflammation, often accompanied byAccepted article preview online 29 April 2014; published online 5 June 2014
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